PIKFYVE and cancer: In addition, low concentrations of PIKFYVE inhibitors that disrupt lysosome homeostasis can work synergistically with other cancer sensitive inhibitors [10], thereby potentially reducing the toxicity of commonly used anti-cancer drugs such as cisplatin and etoposide by increasing efficacy with lower doses [70,71].